Sector
PharmaceuticalsOpen
₹136.25Prev. Close
₹136.25Turnover(Lac.)
₹7.28Day's High
₹139.15Day's Low
₹130.852 Week's High
₹16952 Week's Low
₹103Book Value
₹62.57Face Value
₹10Mkt Cap (₹ Cr.)
151.72P/E
42.62EPS
3.11Divi. Yield
1.13Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Equity Capital | 11.45 | 11.45 | 11.45 | 11.45 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 60.18 | 58.17 | 56.71 | 55.72 |
Net Worth | 71.63 | 69.62 | 68.16 | 67.17 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|---|
Revenue | 133.37 | 126.5 | 131.07 | 137.41 |
yoy growth (%) | 5.43 | -3.48 | -4.61 | 41.16 |
Raw materials | -80.06 | -66.45 | -83.48 | -90.54 |
As % of sales | 60.02 | 52.53 | 63.69 | 65.89 |
Employee costs | -13.72 | -11.79 | -13.57 | -12.85 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|---|
Profit before tax | 13.77 | 24.05 | 12.09 | 9.75 |
Depreciation | -4.25 | -3.94 | -4.38 | -4.13 |
Tax paid | -3.38 | -6.94 | -3.64 | -2.89 |
Working capital | -2.89 | 13.73 | -4.58 | 4.57 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 5.43 | -3.48 | -4.61 | 41.16 |
Op profit growth | -35.41 | 87.26 | -8.16 | 409.08 |
EBIT growth | -41.32 | 64.67 | 14.5 | -2,333.94 |
Net profit growth | -39.31 | 102.52 | 23.1 | -313.53 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,705.55 | 95.71 | 4,09,218.58 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,600.65 | 79.35 | 1,75,226.52 | 667 | 0.45 | 2,536 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,741.9 | 63.7 | 1,26,637.21 | 551 | 0.16 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,554.2 | 24.3 | 1,25,540.69 | 1,303.13 | 1.03 | 4,501.66 | 397.39 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.85 | 15.39 | 1,06,062.83 | 2,961.2 | 0.63 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
E Purushotham
Joint Managing Director & CFO
E Swapnil
Company Sec. & Compli. Officer
Urvashi D Khanna
Non-Executive & Non-Independent Director
E. Smruthi
Independent Director
Prakash Purushottam Wadgaonkar
Independent Director
Anoop Doshi
Independent Director
Dharmaraj Rao
165-A Balaji Bhavan 1st Floor,
Railway Lines,
Maharashtra - 413001
Tel: 91-217-2310267/2310268
Website: http://www.smruthiorganics.com
Email: eaga@smruthiorganics.com
19/20 Jaferbhoy Ind,
1st Floor Makwana Rd, Marol Naka,
Mumbai - 400 059
Tel: 91-022-28594060
Website: www.adriotcorporate.com
Email: info@adroitcorporate.com
Summary
Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995. The Company was promoted by E Puru...
Read More
Reports by Smruthi Organics Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.